Skip to main content
. 2019 Aug 19;9:12062. doi: 10.1038/s41598-019-48593-4

Figure 3.

Figure 3

Survival times during nintedanib treatment for idiopathic pulmonary fibrosis. Differences in median survival times between patients with nausea and those without (A) and between patients with diarrhea and those without (B). The green line represents the survival curve for patients with the adverse effect, while the blue line represents the curve for patients without the adverse effect.